Cargando…
R‐CHOP‐14 versus R‐CHOP‐14/CHASER for upfront autologous transplantation in diffuse large B‐cell lymphoma: JCOG0908 study
The efficiency of upfront consolidation with high‐dose chemotherapy/autologous stem‐cell transplantation (HDCT/ASCT) for newly diagnosed high‐risk diffuse large B‐cell lymphoma (DLBCL) may be influenced by induction chemotherapy. To select better induction chemotherapy regimens for HDCT/ASCT, a rand...
Autores principales: | Kagami, Yoshitoyo, Yamamoto, Kazuhito, Shibata, Taro, Tobinai, Kensei, Imaizumi, Yoshitaka, Uchida, Toshiki, Shimada, Kazuyuki, Minauchi, Koichiro, Fukuhara, Noriko, Kobayashi, Hirofumi, Yamauchi, Nobuhiko, Tsujimura, Hideki, Hangaishi, Akira, Tominaga, Ryo, Suehiro, Youko, Yoshida, Shinichiro, Inoue, Yoshiko, Suzuki, Sachiko, Tokuhira, Michihide, Kusumoto, Shigeru, Kuroda, Junya, Yakushijin, Yoshihiro, Takamatsu, Yasushi, Kubota, Yasushi, Nosaka, Kisato, Morishima, Satoko, Nakamura, Shigeo, Ogura, Michinori, Maruyama, Dai, Hotta, Tomomitsu, Morishima, Yasuo, Tsukasaki, Kunihiro, Nagai, Hirokazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540987/ https://www.ncbi.nlm.nih.gov/pubmed/32767806 http://dx.doi.org/10.1111/cas.14604 |
Ejemplares similares
-
R‐High‐CHOP/CHASER/LEED with autologous stem cell transplantation in newly diagnosed mantle cell lymphoma: JCOG0406 STUDY
por: Ogura, Michinori, et al.
Publicado: (2018) -
Long‐term follow‐up after R‐High CHOP/CHASER/LEED with Auto‐PBSCT in untreated mantle cell lymphoma—Final analysis of JCOG0406
por: Ogura, Michinori, et al.
Publicado: (2023) -
Differential Impact of Relative Dose-Intensity Reductions in Diffuse Large B-Cell Lymphoma Treated with R-CHOP21 or R-CHOP14
por: Gutiérrez, Antonio, et al.
Publicado: (2015) -
Prognostic value of the Kyoto Prognostic Index in higher-risk diffuse large B-cell lymphomas treated by upfront autologous stem cell transplantation in JCOG0908 trial
por: Kobayashi, Tsutomu, et al.
Publicado: (2022) -
Randomised phase II study to optimise melphalan, prednisolone, and bortezomib in untreated multiple myeloma (JCOG1105)
por: Maruyama, Dai, et al.
Publicado: (2020)